随机临床试验中的年度免疫性测量有助于揭示疫苗长期疗效的异质性:一个合并后勤回归建模研究
Julie Dudášová1, Zdeněk Valenta2, Andreea Măgălie3
1Quantitative Pharmacology and Pharmacometrics, MSD Czech Republic, Prague, Czech Republic; First Faculty of Medicine, Charles University, Prague, Czech Republic.
Vaccine
|March 7, 2026
概括
预测长期的疫苗保护是至关重要的. 一个新的模型使用临床试验中的时间依赖性免疫性数据来估计不同群体的疫苗随时间推移的疗效,从而改善耐用性预测.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 生物统计学 生物统计学
背景情况:
- 了解长期疫苗保护和子组差异至关重要,但往往会被推迟到许可后.
- 第三阶段试验通常缺乏用于年度疗效或长期子组分析的力量.
- 来自试验的纵向免疫性数据可以预测疫苗的耐用性.
研究的目的:
- 开发一个建模框架,用时间依赖的免疫性数据来预测疫苗诱导保护的耐用性.
- 评估疫苗在特定的人口分组的时间效果.
主要方法:
- 将加权,横截面聚合的物流回归模型应用于两个第三期试验的免疫性副研究.
- 嵌入了依赖时间的免疫性标记,以预测保护的耐用性.
- 分析了不同年龄和血清状况子组的登革热和疹疫苗的数据.
主要成果:
- 该模型通过结合纵向免疫性数据,精确估计了随时间变化的疫苗疗效.
- 与传统的病例计数方法相比,这种方法提高了精度.
- 该框架成功地预测了子组中的保护耐用性,而不需要绝对的保护相关值.
结论:
- 建模时间依赖的免疫性数据加速了对疫苗保护持久性的理解.
- 这一框架增强了对不同人群的长期疫苗疗效的预测.
- 每年收集免疫性数据和试验中的建模可以指导有效的疫苗开发,以获得持续的保护.
相关概念视频
Immunological Memory
17.6K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.6K
Vaccinations
52.9K
Overview
52.9K
Cells of the Adaptive Immune Response
9.7K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.7K
Bioequivalence studies: Biowaivers
357
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
357


